Substance / Medication

Bazedoxifene acetate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

No related conditions have been mapped yet. Condition-intervention linkages are derived from SNOMED CT relationships and will expand as the knowledge graph grows.

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
[Pharmacology profile and clinical findings of Viviant(®) (bazedoxifene acetate) tablet ].
Harada Takuma, Ochi Yasuo, Ochi Hiroshi · Nihon Yakurigaku Zasshi · 2011
PMID: 21828941Review
Bazedoxifene acetate for the management of postmenopausal osteoporosis.
Palacios S · Drugs Today (Barc) · 2011
PMID: 21494696Review
Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers.
Yeun Ji-Sun, Kan Hye-Su, Lee Minyu et al. · Transl Clin Pharmacol · 2020
PMID: 32656161OtherFull text (PMC)
A stability-indicating HPLC method for the determination of bazedoxifene acetate and its related substances in active pharmaceutical ingredient.
Visweswara Rao Karri, Reddy Kesareddy Padmaja, Kumari Kondapaturu Siva et al. · J Chromatogr Sci · 2013
PMID: 22865837Other
Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model.
Ethun Kelly F, Wood Charles E, Cline J Mark et al. · Menopause · 2013
PMID: 23793168PreclinicalFull text (PMC)
Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys.
Ethun Kelly F, Wood Charles E, Register Thomas C et al. · Menopause · 2012
PMID: 23103754PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Bazedoxifene acetate (substance)
SNOMED CT
702401005
UMLS CUI
C1571574

Clinical Data

This intervention maps to 0 entities in the Ltrl knowledge graph.

0
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.